Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population
Yochai Schonmann, Hanny Yeshua, Itay Bentov, et al.
Digestive and Liver Disease (2020) Vol. 53, Iss. 1, pp. 79-85
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

An international multidisciplinary consensus statement on MAFLD and the risk of CVD
Xiaodong Zhou, Giovanni Targher, Christopher D. Byrne, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 773-791
Open Access | Times Cited: 93
Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease
Stefano Ballestri, Alessandro Mantovani, Enrica Baldelli, et al.
Diagnostics (2021) Vol. 11, Iss. 1, pp. 98-98
Open Access | Times Cited: 73
Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality
Stefano Ballestri, Alessandro Mantovani, Maria Di Girolamo, et al.
Metabolism and Target Organ Damage (2023) Vol. 3, Iss. 1, pp. 1-1
Open Access | Times Cited: 28
Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
Yulino Castillo-Núñez, Paloma Almeda‐Valdés, Guillermo González-Gálvez, et al.
Current Diabetes Reports (2024) Vol. 24, Iss. 7, pp. 158-166
Closed Access | Times Cited: 10
FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Marcello Dallio, Mario Romeo, Fiammetta Di Nardo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 761-761
Open Access | Times Cited: 1
Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality
Mayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 55, Iss. 3, pp. 292-301
Open Access | Times Cited: 56
Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study
Galit Weinstein, Adrienne O’Donnell, Kendra Davis‐Plourde, et al.
Journal of Alzheimer s Disease (2022) Vol. 86, Iss. 3, pp. 1371-1383
Closed Access | Times Cited: 30
Association between FIB-4, all-cause mortality, cardiovascular mortality, and cardiovascular disease risk among diabetic individuals: NHANES 1999–2008
Lihua Guan, Lei Li, Yutong Zou, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 11
Liver Fibrosis Scores and Hospitalization, Mechanical Ventilation, Severity, and Death in Patients with COVID-19: A Systematic Review and Dose-Response Meta-Analysis
Menglu Liu, Kaibo Mei, Ziqi Tan, et al.
Canadian Journal of Gastroenterology and Hepatology (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 18
Hepatokine and Proinflammatory Cytokine Profile in Patients with Carotid Atherosclerosis and Metabolic Dysfunction-Associated Steatotic Liver Disease
A.D. Cano-Contreras, María del Rocío Francisco, José Luis Vargas-Basurto, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 978-978
Open Access
Liver Fibrosis Marker FIB‐4 Is Associated With Hepatic and Extrahepatic Malignancy Risk in a Population‐Based Cohort Study
Shira Zelber‐Sagi, Yochai Schonmann, Galit Weinstein, et al.
Liver International (2025) Vol. 45, Iss. 6
Closed Access
Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Marco Castellana, Rossella Donghia, Vito Guerra, et al.
The American Journal of Gastroenterology (2021) Vol. 116, Iss. 9, pp. 1833-1841
Closed Access | Times Cited: 22
Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases (MMPs) in liver fibrosis
Usman Sabir, Hongmei Gu, Dawei Zhang
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 4932-4962
Open Access | Times Cited: 9
Liver Fibrosis Scores and Clinical Outcomes in Patients With COVID-19
Jing Zhang, Fuwei Liu, Tiangang Song, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 13
The safety and efficacy evaluation of sodium-glucose co-transporter 2 inhibitors for patients with non-alcoholic fatty liver disease: An updated meta-analysis
Man-Qiu Mo, Zichun Huang, Yuzhen Liang, et al.
Digestive and Liver Disease (2021) Vol. 54, Iss. 4, pp. 461-468
Closed Access | Times Cited: 18
FAN score comprising fibrosis-4 index, albumin–bilirubin score and neutrophil–lymphocyte ratio is a prognostic marker of urothelial carcinoma patients treated with pembrolizumab
Atsunari Kawashima, Yoshiyuki Yamamoto, Mototaka Sato, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 16
Does an Aspirin a Day Take the MASLD Away?
Amedeo Lonardo, Ming‐Hua Zheng
Advances in Therapy (2024) Vol. 41, Iss. 7, pp. 2559-2575
Closed Access | Times Cited: 2
The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study
Galit Weinstein, Yochai Schonmann, Hanny Yeshua, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5385-5397
Open Access | Times Cited: 2
Epicardial and liver fat implications in albuminuria: a retrospective study
Carolina M. Perdomo, Nerea Martín‐Calvo, Ana Ezponda, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Identifying patient subgroups in MASLD and MASH-associated fibrosis: molecular profiles and implications for drug development
Manuel A. González Hernández, Lars Verschuren, Martien Caspers, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Diabetic Kidney Disease, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease: A New Triumvirate?
Carolina M. Perdomo, Nuria Garcı́a-Fernández, Javier Escalada
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 2040-2040
Open Access | Times Cited: 15
Liver Fibrosis Marker and Postoperative Mortality in Patients Without Overt Liver Disease
Shira Zelber‐Sagi, Vikas N. O’Reilly-Shah, Christine T. Fong, et al.
Anesthesia & Analgesia (2022)
Closed Access | Times Cited: 11
High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China
Xinyan Yu, Chen Chen, Yi Guo, et al.
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 1621-1631
Open Access | Times Cited: 12
Noninvasive Algorithms for the Case Finding of “At-Risk” Patients with NAFLD
Laurent Castéra, Jérôme Boursier
Seminars in Liver Disease (2022) Vol. 42, Iss. 03, pp. 313-326
Closed Access | Times Cited: 9
Nutritional patterns as machine learning predictors of liver health in a population of elderly subjects
Luisa Lampignano, Rossella Tatoli, Rossella Donghia, et al.
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 33, Iss. 11, pp. 2233-2241
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top